SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,499.17 -455.59
( -0.58%)

Global Indices

Nasdaq

54,056.75 150.65
(0.28%)

Dow Jones

7,778.11 47.15
(0.61%)

Hang Seng

65,597.55 -85.71
(-0.13%)

Nikkei 225

10,909.12 41.23
(0.38%)

Forex

USD-INR

95.20 0.13
(0.14%)

EUR-INR

109.83 0.08
(0.08%)

GBP-INR

128.13 0.14
(0.11%)

JPY-INR

0.60 0.00
(-0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Indrayani Biotech Ltd

Industry : Diversified - Medium / Small

BSE Code

ISIN Demat

Book Value()

526445

INE007C01021

13.440188

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

79.27

68.07

EPS(TTM)

Face Value()

Div & Yield %

0.11

Back

Wanbury standalone net profit rises 7.11% in the March 2026 quarter

Jun 01,2026

Net profit of Wanbury rose 7.11% to Rs 21.70 crore in the quarter ended March 2026 as against Rs 20.26 crore during the previous quarter ended March 2025. Sales declined 4.31% to Rs 164.58 crore in the quarter ended March 2026 as against Rs 172.00 crore during the previous quarter ended March 2025.

For the full year,net profit rose 116.61% to Rs 66.13 crore in the year ended March 2026 as against Rs 30.53 crore during the previous year ended March 2025. Sales rose 8.47% to Rs 650.27 crore in the year ended March 2026 as against Rs 599.51 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	164.58	172.00	-4	650.27	599.51	8
OPM %	18.13	17.23	-	16.42	12.73	-
PBDT	21.99	22.43	-2	77.71	42.86	81
PBT	18.76	19.06	-2	63.40	29.55	115
NP	21.70	20.26	7	66.13	30.53	117

78,499.17 -455.59 ( -0.58%)

54,056.75 150.65 (0.28%)

7,778.11 47.15 (0.61%)

65,597.55 -85.71 (-0.13%)

10,909.12 41.23 (0.38%)

95.20 0.13 (0.14%)

109.83 0.08 (0.08%)

128.13 0.14 (0.11%)

0.60 0.00 (-0.12%)